For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Treatment (Everolimus) | Patients will take 10 mg (1 tablet) of everolimus each day for 4 months Everolimus: 10 mg tablets | 0 | None | 3 | 20 | 20 | 20 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| chest pain | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| flank pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| dysuria | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| pneumonitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| heart palpitations | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Maculopapular rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| diarrhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Leukocyte decrease | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Hypertriglyceridemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Pruritis | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| constipation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Xerostomia | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Lymphocyte decrease | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Hyperglycemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Metabolism + nutrional disorders - other | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Dysgeusia | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| cough | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Epistaxis | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Skin + subcutaneous tissue disorders - other | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Chills | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| fever | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| limb edema | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| UTI | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Elevated creatinine | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Neutrophil decrease | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| headache | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Nervous system disorders - other | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| pneumonitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| acneiform rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| involuntary movements | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| oral mucositis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Alanine aminotransferase increase | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| anemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Aspartate aminotransferase increase | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| fatigue | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hypercholesterolemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |